SCHEMBL3877845

SCHEMBL3877845

CCn1cnc(C(N)=O)c1Nc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.43
ILK Q13418 1/20 0.43
GAA P10253 4/20 0.38
MAPT P10636 3/20 0.38
CDK4 P11802 3/20 0.38
CCNA2 P20248 3/20 0.38
CDK2 P24941 3/20 0.38
CCND3 P30281 3/20 0.38
CDK6 Q00534 2/20 0.38
AURKA O14965 1/20 0.38
TTK P33981 1/20 0.38
PLK1 P53350 1/20 0.38
CCNA1 P78396 1/20 0.38
PLK3 Q9H4B4 1/20 0.38
PLK2 Q9NYY3 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
KDM4E B2RXH2 2/20 0.37
GFER P55789 1/20 0.37
ALDH1A1 P00352 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364010 0.75 ALDH1A1 (0.36) MAPTCDK2KDM4EALDH1A1
SCHEMBL9368918 0.75 ALDH1A1 (0.47) GAAMAPTPKMALDH1A1HPGD
SCHEMBL9668607 0.74 KDM4E (0.35) GAAMAPTPKMTSHRKDM4E
SCHEMBL1951450 0.71 ALDH1A1 (0.42) GAACDK2PKMTSHRKDM4E
SCHEMBL3452770 0.71 ALDH1A1 (0.54) GAAMAPTCDK2KDM4EALDH1A1
SCHEMBL9363575 0.68 PKM (0.51) GAAPKMTSHRALDH1A1
SCHEMBL11551662 0.65 PKM (0.59) GAAPKMTSHRALDH1A1
SCHEMBL9367365 0.65 PKM (0.59) GAAPKMTSHRALDH1A1HPGD
SCHEMBL9367320 0.65 ALDH1A1 (0.35) PDE4BGAACDK2ALDH1A1PDE4A
SCHEMBL20552051 0.64 PKM (0.42) GAACDK2PKMTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2094670-A1 HETEROCYCLYC SULFONAMIDES HAVING EDG-I ANTAGONISTIC ACTIVITY AstraZeneca AB (SE) 2009-09-02 EP disclosed
WO-2008056150-A1 HETEROCYCLYC SULFONAMIDES HAVING EDG-I ANTAGONISTIC ACTIVITY ASTRAZENECA AB (SE) 2008-05-15 WO disclosed